Lotufo J P, Ejzenberg B, Vieira S, Mukai L, Macedo H, Yamashita C, Ventura G, Baldacci E R, Okay Y
Département de Pédiatrie de la Faculté de l'Université de São Paulo, Hôpital Universitaire, São Paulo, Brésil.
Rev Mal Respir. 1998 Jun;15(3):255-61.
This study investigated the efficacy of a system for continuous nebulization of terbutaline sulphate in the treatment of acute asthmatic crises in children. The equipment consisted of a condensation nebulizer attached to a 40 liter acrylic tent placed around the patient's head. A prospective, randomized and open clinical trial was conducted. Twenty eight children, 2 to 5 year-old, in acute asthmatic crises were selected. Fourteen were nebulized with terbutaline sulphate while in the control group the aerosolization was proceeded only with half diluted physiologic serum. All patients were administered aminophyline intravenously. The parameter used to evaluate the efficacy of the terbutaline sulphate nebulizing system was clinical improvement measured by the Wood-Downes Score. Two additional parameters indicating terbutaline sulphate absorption were used: reduction of potassium seric levels and positive chronotropic effect. The group treated with terbutaline sulphate showed greater clinical improvement than control group at the 12 hour protocol evaluation as well as lower seric potassium level. A positive chronotropic effect was also observed at the final protocol evaluation. The data showed, preliminarily, that (a) the system for continuous nebulization of terbutaline sulphate was effective in treatment of children's acute asthmatic crises, and (b) there was evidence attesting to the absorption of terbutaline sulphate by the children treatment with it.
本研究调查了硫酸特布他林持续雾化系统治疗儿童急性哮喘危象的疗效。该设备包括一个冷凝雾化器,连接到置于患儿头部周围的40升丙烯酸帐篷。进行了一项前瞻性、随机、开放性临床试验。选取了28名2至5岁处于急性哮喘危象的儿童。14名儿童用硫酸特布他林进行雾化,而对照组仅用半稀释的生理血清进行雾化。所有患者均静脉注射氨茶碱。用于评估硫酸特布他林雾化系统疗效的参数是通过Wood-Downes评分衡量的临床改善情况。还使用了另外两个表明硫酸特布他林吸收情况的参数:血清钾水平降低和正性变时作用。在12小时方案评估时,硫酸特布他林治疗组的临床改善情况优于对照组,血清钾水平也更低。在最终方案评估时也观察到了正性变时作用。数据初步显示,(a)硫酸特布他林持续雾化系统对治疗儿童急性哮喘危象有效,(b)有证据证明接受该治疗的儿童吸收了硫酸特布他林。